Speratum Biopharma is comprised of a team of talented scientists, clinicians, and executives committed to developing breakthrough science from bench to bedside. Meet our team below:
Leadership
Christian Marín Müller
MS, PhD
X
Christian Marín Müller, MS, PhD
- Founder and Chief Executive Officer
- Co-inventor of Speratum’s technologies
- PhD in Molecular Virology and Microbiology Baylor College of Medicine
- MSc Entrepreneurship Case Western Reserve University
- BS Florida Tech
Osvaldo Vega-Martínez
MS
X
Osvaldo Vega-Martínez, MS
- Chief Science Officer
- Co-inventor of Speratum’s technologies
- 6+ years of experience managing translational biotechnology research
- MS in Human Genomics University of Costa Rica
Jilma Aleman Laporte
PhD, DVM
X
Jilma Aleman Laporte, PhD, DVM
- 6+ years leading laboratory animal studies
- AAALAC-accredited Animal Care and Use Program Lead
- Veterinary attendant in animal facility
- PhD in Experimental and Comparative Pathology, University of Sao Paulo
Laura Chaves-Martínez
BSc
X
Laura Chaves-Martínez, BSc
- Scientific lead, Nanotechnology Department
- 5+ years of experience in basic and translational research in drug-delivery systems and polymer science
- Industrial Chemistry and Polymer Science National University of Costa Rica
Melvin Nuñez-Viquez
BS
X
Melvin Nuñez-Viquez, BS
- Project Manager and Administrator
- 20+ years in project management and administration for startups, universities, and mid-sized companies
- BS in Management, University of Costa Rica
María José Lopez-Brenes
BSc
X
María José Lopez-Brenes, BSc
- Scientific Lead, Cell culture
- 3 years of experience in basic research with emphasis in in vitro tissue culture
- Biology and Biotechnology National University of Costa Rica
Board of Directors with proven track record
Andy Weymann
MD, MBA
X
Andy Weymann, MD, MBA
- CEO Gelmetix
- Investor, executive, director, or advisor in several industry boards
- Former CMO of Smith+Nephew
- 25+ years of experience in medical device, and biotechnology companies
Thilo Bayrhoffer
MD, MBA
X
Thilo Bayrhoffer, MD, MBA
- Strategy consultant and business development executive
- Global experience in pharmaceutical and medical device fields.
- Expertise in analytics, forecasting, valuation, and portfolio strategy development.
Peter Heeckt
MD, PhD
X
Peter Heeckt, MD, PhD
- Adjunct Professor of Surgery, University of Ulm
- Former CMO, Bioventus, Smith+Nephew
- Medical Director, Fresenius
- Surgeon with 20+ years of diverse industry leadership in major medical device and biotechnology companies
Allan Boruchowicz
BS
X
Allan Boruchowicz, Bs
- Founder and Managing Director, Carao Ventures
- 9+ years working with and investing in startups in Latin America and the U.S.
- 14+ years managing private equity investments BS in Management, Babson College
Christian Marín-Müller
MS - PhD
X
Christian Marín Müller, MS, PhD
- Founder and Chief Executive Officer
- Co-inventor of Speratum’s technologies
- PhD in Molecular Virology and Microbiology
- Baylor College of Medicine
- MSc Entrepreneurship
- Case Western Reserve University
- BS Florida Tech
Petra Molan
PharmD - MSc
X
Petra Molan, PharmD, MSc
- Executive, Director, Advisor in Pharma and Biotech.
- Former Bayer, Shire, Takeda, Horizon executive with many years of successful commercialization track record.
Strong leadership team and scientific advisory board
Changyi Chen
MD, PhD
X
Changyi Chen, MD, PhD
- Director, Molecular Surgeon Center
- Molecular Surgery Endowed Chair
- Baylor College of Medicine
- Co-inventor of Speratum’s technologies
- Senior Member, Nat. Academy of Inventors
- Over 200+ publications
Qizhi Yao
MD, PhD
X
Qizhi Yao, MD, PhD
- Professor, Virology & Microbiology
- Professor, Pathology and Immunology Baylor College of Medicine
- Co-inventor of Speratum’s technologies RNAi-based therapeutics and HIV vaccine development
- Over 150+ publications
Jian-Ming Lu
MS, PhD
X
Jian-Ming Lu, MS, PhD
- Assistant Professor of Surgery Baylor College of Medicine
- Co-inventor of Speratum’s technologies
- 20+ years focusing on basic science and translational development projects in clinical diseases
Peter Heeckt
MD, PhD
X
Peter Heeckt, MD, PhD
- Adjunct Professor of Surgery, University of Ulm
- Former CMO, Bioventus, Smith+Nephew
- Medical Director, Fresenius
- Surgeon with 20+ years of diverse industry leadership in major medical device and biotechnology companies
Wen Wee Ma
MBBS
X
Wen Wee Ma, MBBS
- Professor of Oncology Mayo Clinic Department of Oncology
- Early Cancer Therapeutics Program
- Principal investigator in clinical trials evaluating first-in-human agents with an emphasis in pancreatic cancer
Jose Vega-Baudritt
PhD
X
Jose Vega-Baudritt, PhD
- Director of the National Laboratory for Nanotechnology (LANOTEC) of Costa Rica
- PhD in nanotechnology, MS in chemical engineering of polymers, and a specialty in biodegradable polymers
- 150+ scientific articles, 20 book chapters, multiple patents
Anthony J.M. Bauer
PhD
X
Anthony J.M. Bauer, PhD
- Associate Professor of Physiology & Pharmacology Liberty University College of Osteopathic Medicine
- Associate Professor of Medicine Division of Gastroenterology, Hepatology & Nutrition, University of Pittsburgh
- Over 200+ publications
Michael H. Schoenberg
MD, PhD
X
Michael H. Schoenberg, MD, PhD
- Adjunct Professor of Surgery, Ludwig-Maximilians-University, Munich
- Former Chairman and Medical Director Department of Surgery, Red Cross Hospital Gastrointestinal cancer surgeon and patient oncologic care manager
Wei Sen Wong
PhD
X
Wei Sen Wong, PhD
- President of Houston HMJ Associates. PhD in polymer chemistry from Northeastern University
- 36+ years of experience in polymer characterization, as director of GPC and DSV laboratories at Shell Company and Malvern/Viscotek, respectively.